Company announcements · 23/10/20261 min read
Bolt Biotherapeutics announces acquisition of Prana Therapies and $120 million concurrent private placement to advance PRA-216 in multiple high-value inflammatory indications
Summary
Redwood City, California, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) today announced the acquisition of Prana Therapies, Inc., a clinical-stage biotechnology...
Original source language: GlobeNewswire — Mergers and AcquisitionsOpen original release →